Zobrazeno 1 - 10
of 165
pro vyhledávání: ''
Publikováno v:
Journal of Neuro-Oncology. 152:405-413
The disadvantages of biopsy for lesions in the basal ganglia and thalamus include a risk of various complications, difficulty in selecting the target tissue in some cases due to indistinct neuroimaging findings and limited availability of sample tiss
Autor:
Rajan Jain, Ruoyu Luie Wang, Sylvia Kurz, Daniel A. Orringer, Douglas Kondziolka, John G. Golfinos, Guillaume Madelin, Yulin Ge, Christine Cordova, Pradeep Kumar Gupta, Mickael Tordjman, Mariana Lazar
Publikováno v:
J Neurooncol
PURPOSE: Resting state functional magnetic resonance imaging (rsfMRI) is an emerging tool to explore the functional connectivity of different brain regions. We aimed to assess the disruption of functional connectivity of the Default Mode Network (DMN
Germline ALK variations are associated with a poor prognosis in glioma and IDH-wildtype glioblastoma
Autor:
Xiaoyu Zhou, Chen Luo, Shuai Wu, Shengzhou Wang, N U Farrukh Hameed, Peng-Jie Hong, Linghao Bu
Publikováno v:
Journal of Neuro-Oncology. 152:27-36
Glioma is the most common primary brain tumor. Clear classification is crucial for accurate diagnosis and individualized treatment. Histopathological characteristics and genetic alterations have shown to be related to prognosis and treatment response
Autor:
Sunit Das, Arjun Sahgal, Georg A. Bjarnason, Eshetu G. Atenafu, Nir Lipsman, Sten Myrehaug, Jay Detsky, Hany Soliman, Mikki Campbell, K. Liang Zeng, Monica Foster, Arman Sarfehnia, Pejman Jabehdar Maralani, Mark Ruschin, Chia-Lin Tseng, Zain A. Husain
Publikováno v:
Journal of Neuro-Oncology. 152:173-182
The concept of a radioresistant (RR) phenotype has been challenged with use of stereotactic body radiotherapy (SBRT). We compared outcomes following SBRT to RR spinal metastases to a radiosensitive cohort. Renal cell, melanoma, sarcoma, gastro-intest
Autor:
Takenori Kato, Risa Ito, Kou Okada, Toshinori Hasegawa, Takafumi Tanei, Eisuke Tsukamoto, Kazuki Ishii, Takehiro Naito, Yuuta Kouketsu
Publikováno v:
Journal of Neuro-Oncology. 151:145-156
To evaluate the predictors of long-term tumor control following stereotactic radiosurgery (SRS) for Koos grade 4 vestibular schwannomas (VSs).Overall, 203 sporadic VS patients with compression of the brainstem were treated with SRS. The median tumor
Autor:
Nafisha Lalani, Lovedeep Gondara, Alan Nichol, Kevin Y. Fan, Nathalie LeVasseur, Kaylie Willemsma, Andra Krauze, F. Hsu
Publikováno v:
Journal of Neuro-Oncology. 151:231-240
This study aimed to investigate whether systemic therapy (ST) use surrounding radiation therapy (RT) predicts overall survival (OS) after RT for patients with brain metastases (BMs). Provincial RT and pharmacy databases were used to review all adult
Autor:
Ian F. Parney, Anshit Goyal, Alfredo Quinones-Hinojosa, Mohamad Bydon, Jamie J. Van Gompel, Elizabeth Yan, Terry C. Burns, Benjamin T. Himes, Mohammed Ali Alvi, Panagiotis Kerezoudis, Desmond A. Brown, Kaisorn L. Chaichana
Publikováno v:
Journal of Neuro-Oncology. 149:293-303
WHO grades II (atypical) and III (malignant) meningiomas are associated with significant morbidity and mortality. The role of adjuvant radiotherapy (RT) in management remains controversial. The goal of this study was to evaluate the impact of adjuvan
Autor:
Saman Sizdahkhani, William J. Mack, Li Ding, Neal H. Nathan, Michelle Connor, Frank J. Attenello
Publikováno v:
J Neurooncol
PURPOSE: Unplanned readmission of post-operative brain tumor patients is often attributed to hospital and patient characteristics and is associated with higher mortality and cost. Previous studies demonstrate multiple patient outcome disparities in s
Autor:
Florien W. Boele, Martin Klein, Femke Jansen, Irma M. Verdonck-de Leeuw, Susan C Short, Jaap C. Reijneveld, Jan J. Heimans, David Meads
Publikováno v:
Boele, F W, Meads, D, Jansen, F, Verdonck-de Leeuw, I M, Heimans, J J, Reijneveld, J C, Short, S C & Klein, M 2020, ' Healthcare utilization and productivity loss in glioma patients and family caregivers : the impact of treatable psychological symptoms ', Journal of Neuro-Oncology, vol. 147, no. 2, pp. 485-494 . https://doi.org/10.1007/s11060-020-03454-3
Journal of Neuro-Oncology
Journal of Neuro-Oncology, 147(2), 485-494. Kluwer Academic Publishers
Journal of Neuro-Oncology
Journal of Neuro-Oncology, 147(2), 485-494. Kluwer Academic Publishers
Background Gliomas are associated with significant healthcare burden, yet reports of costs are scarce. While many costs are unavoidable there may be treatable symptoms contributing to higher costs. We describe healthcare and societal costs in glioma
Autor:
Evan Luther, Daniel G Eichberg, Long Di, Rita Bhatia, Ricardo J. Komotar, Aria M. Jamshidi, Alexa Semonche, Alexis Morell, Christopher Chin, Ashish H. Shah, Michael E. Ivan
Publikováno v:
Journal of Neuro-Oncology. 147:671-679
Although non-enhancing lesions suspicious for glioma are usually assumed to be low grade glioma (LGG), some high grade glioma (HGG) do not enhance, which may lead to a delay in biopsy and/or resection, diagnosis, and treatment initiation. Thus, there